The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Fibrin Clot Structure and Function: A Role in the Pathophysiology of Arterial and Venous Thromboembolic Diseases
Open accessAbstract
The formation of fibrin clots that are relatively resistant to lysis represents the final step in blood coagulation. We discuss the genetic and environmental regulators of fibrin structure in relation to thrombotic disease. In addition, we discuss the implications of fibrin structure for treatment of thrombosis. Fibrin clots composed of compact, highly branched networks with thin fibers are resistant to lysis. Altered fibrin structure has consistently been reported in patients with several diseases complicated by thromboembolic events, including patients with acute or prior myocardial infarction, ischemic stroke, and venous thromboembolism. Relatives of patients with myocardial infarction or venous thromboembolism display similar fibrin abnormalities. Low-dose aspirin, statins, lowering of homocysteine, better diabetes control, smoking cessation, and suppression of inflammatory response increase clot permeability and susceptibility to lysis. Growing evidence indicates that abnormal fibrin properties represent a novel risk factor for arterial and venous thrombotic events, particularly of unknown etiology in young and middle-aged patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism
Glynn, R. J., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900241 · Cited by 752
Roldan, A. L., Cubellis, M. V., Masucci, M. T., Behrendt, N., Lund, L. R., Danø, K., Appella, E., & Blasi, F. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08132.x · Cited by 603
Why Have Antioxidants Failed in Clinical Trials?
Steinhubl, S. R. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.02.003 · Cited by 422
Multiscale Mechanics of Fibrin Polymer: Gel Stretching with Protein Unfolding and Loss of Water
Brown, A. E. X., Litvinov, R. I., Discher, D. E., Purohit, P. K., & Weisel, J. W. (2009) · Science · doi:10.1126/science.1172484 · Cited by 416
Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin
Spraggon, G., Everse, S. J., & Doolittle, R. F. (1997) · Nature · doi:10.1038/38947 · Cited by 382
Meltzer, M. E., Lisman, T., de Groot, P. G., Meijers, J. C. M., le Cessie, S., Doggen, C. J. M., & Rosendaal, F. R. (2010) · Blood · doi:10.1182/blood-2010-02-267740 · Cited by 364
Collet, J. P., Allali, Y., Lesty, C., Tanguy, M. L., Silvain, J., Ankri, A., Blanchet, B., Dumaine, R., Gianetti, J., Payot, L., et al. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000241589.52950.4c · Cited by 348
Ariëns, R. A. S., Philippou, H., Nagaswami, C., Weisel, J. W., Lane, D. A., & Grant, P. J. (2000) · Blood · doi:10.1182/blood.v96.3.988 · Cited by 324
Polyphosphate exerts differential effects on blood clotting, depending on polymer size
Smith, S. A., Choi, S. H., Davis-Harrison, R., Huyck, J., Boettcher, J., Rienstra, C. M., & Morrissey, J. H. (2010) · Blood · doi:10.1182/blood-2010-01-266791 · Cited by 307
γ-γ Cross-linking sites in human and bovine fibrin
Chen, R., & Doolittle, R. F. (1971) · Biochemistry · doi:10.1021/bi00800a021 · Cited by 299
The elasticity of an individual fibrin fiber in a clot
Collet, J., Shuman, H., Ledger, R. E., Lee, S., & Weisel, J. W. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504120102 · Cited by 294
ROSENDAAL, F. R., & REITSMA, P. H. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03394.x · Cited by 291
Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis
Lisman, T., de Groot, P. G., Meijers, J. C. M., & Rosendaal, F. R. (2005) · Blood · doi:10.1182/blood-2004-08-3253 · Cited by 282
Undas, A., Brummel-Ziedins, K. E., & Mann, K. G. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000151647.14923.ec · Cited by 275
Self-citationThe effect of fibrin structure on fibrinolysis.
Gabriel, D. A., Muga, K., & Boothroyd, E. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35759-4 · Cited by 269
Bini, A., Fenoglio, J. J., Mesa-Tejada, R., Kudryk, B., & Kaplan, K. L. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.1.109 · Cited by 268
Undas, A., Zawilska, K., Ciesla-Dul, M., Lehmann-Kopydłowska, A., Skubiszak, A., Ciepłuch, K., & Tracz, W. (2009) · Blood · doi:10.1182/blood-2009-05-222380 · Cited by 260
Self-citationKant, J. A., Fornace, A. J., Saxe, D., Simon, M. I., McBride, O. W., & Crabtree, G. R. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.8.2344 · Cited by 257
Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions
Undas, A., Brummel-Ziedins, K. E., & Mann, K. G. (2007) · Blood · doi:10.1182/blood-2006-01-010645 · Cited by 254
Self-citationVeklich, Y. I., Gorkun, O. V., Medved, L. V., Nieuwenhuizen, W., & Weisel, J. W. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38688-0 · Cited by 244
Fatah, K., Silveira, A., Tornvall, P., Karpe, F., Blombäck, M., & Hamsten, A. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650618 · Cited by 221
The influence of type 2 diabetes on fibrin structure and function
Dunn, E. J., Ariëns, R. A. S., & Grant, P. J. (2005) · Diabetologia · doi:10.1007/s00125-005-1742-2 · Cited by 221
Self-citationPolyphosphate enhances fibrin clot structure
Smith, S. A., & Morrissey, J. H. (2008) · Blood · doi:10.1182/blood-2008-03-145755 · Cited by 214
Karimi, M., Bereczky, Z., Cohan, N., & Muszbek, L. (2009) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0029-1225765 · Cited by 213
Undas, A., Wiek, I., Stêpień, E., Zmudka, K., & Tracz, W. (2008) · Diabetes Care · doi:10.2337/dc08-0282 · Cited by 213
Self-citationYang, Z., Mochalkin, I., & Doolittle, R. F. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14156 · Cited by 200
Undas, A., Szułdrzynski, K., Stepien, E., Zalewski, J., Godlewski, J., Tracz, W., Pasowicz, M., & Zmudka, K. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.05.028 · Cited by 191
Self-citationLim, B. C., Ariëns, R. A., Carter, A. M., Weisel, J. W., & Grant, P. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13135-2 · Cited by 190
Self-citationAspirin Alters the Cardioprotective Effects of the Factor XIII Val34Leu Polymorphism
Undas, A., Sydor, W., Brummel, K. E., Musiał, J., Mann, K. G., & Szczeklik, A. (2003) · Circulation · doi:10.1161/01.cir.0000047062.03282.a3 · Cited by 189
Self-citationMills, J. D., Ariëns, R. A. S., Mansfield, M. W., & Grant, P. J. (2002) · Circulation · doi:10.1161/01.cir.0000033221.73082.06 · Cited by 186
Heritability of Clot Formation, Morphology, and Lysis: The EuroCLOT Study
Carter, A. M., Cymbalista, C. M., Spector, T. D., & Grant, P. J. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.153221 · Cited by 179
Dunn, E. J., Philippou, H., Ariëns, R. A. S., & Grant, P. J. (2006) · Diabetologia · doi:10.1007/s00125-006-0197-4 · Cited by 177
Self-citationWolberg, A. S., Monroe, D. M., Roberts, H. R., & Hoffman, M. (2003) · Blood · doi:10.1182/blood-2002-08-2527 · Cited by 175
Fatah, K., Hamsten, A., Blombäck, B., & Blombäck, M. (1992) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1656337 · Cited by 174
Fibrinogen and the Risk of Thrombosis
de Moerloose, P., Boehlen, F., & Neerman-Arbez, M. (2010) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0030-1248720 · Cited by 171
Bini, A. (1989) · Arteriosclerosis An Official Journal of the American Heart Association Inc · Cited by 169
Beneficial effects of metformin on haemostasis and vascular function in man
Grant, P. J. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(03)72787-6 · Cited by 167
Mutch, N. J., Engel, R., Uitte de Willige, S., Philippou, H., & Ariëns, R. A. S. (2010) · Blood · doi:10.1182/blood-2009-11-254029 · Cited by 167
Self-citationCampbell, R. A., Overmyer, K. A., Selzman, C. H., Sheridan, B. C., & Wolberg, A. S. (2009) · Blood · doi:10.1182/blood-2009-06-228940 · Cited by 167
Role of the .alpha.C Domains of Fibrin in Clot Formation
Gorkun, O. V., Veklich, Y. I., Medved', L. V., Henschen, A. H., & Weisel, J. W. (1994) · Biochemistry · doi:10.1021/bi00188a031 · Cited by 160
Molecular Mechanisms Affecting Fibrin Structure and Stability
Lord, S. T. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.213389 · Cited by 159
Longstaff, C., Thelwell, C., Williams, S. C., Silva, M. M., Szabó, L., & Kolev, K. (2010) · Blood · doi:10.1182/blood-2010-06-290338 · Cited by 151
Pratt, K. P., Côté, H. C. F., Chung, D. W., Stenkamp, R. E., & Davie, E. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7176 · Cited by 150
Sauls, D. L., Lockhart, E. L., WARREN, M. E., et al. (2006) · Biochemistry · doi:10.1021/bi052076j · Cited by 141
Bjornsson, T. D., Schneider, D., & Berger, H. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21331-3 · Cited by 139
High dose factor VIIa improves clot structure and stability in a model of haemophilia B
Wolberg, A. S., Allen, G. A., Monroe, D. M., Hedner, U. K. E., Roberts, H. R., & Hoffman, M. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05820.x · Cited by 138
Undas, A., Celińska‐Löwenhoff, M., Löwenhoff, T., & Szczeklik, A. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01882.x · Cited by 138
Self-citationPlasma Homocysteine Affects Fibrin Clot Permeability and Resistance to Lysis in Human Subjects
Undas, A., Brożek, J., Jankowski, M., Siudak, Z., Szczeklik, A., & Jakubowski, H. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000219688.43572.75 · Cited by 137
Self-citationNeeves, K. B., Illing, D. A. R., & Diamond, S. L. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2009.12.4275 · Cited by 134
Altered Fibrin Clot Structure/Function in Patients With Cryptogenic Ischemic Stroke
Undas, A., Podolec, P. S., Zawilska, K., Pieculewicz, M., Jedliński, I. M., Stępień, E. Ł., Konarska-Kuszewska, E., Węglarz, P., Duszyńska, M., Hanschke, E., et al. (2009) · Stroke · doi:10.1161/strokeaha.108.532812 · Cited by 133
Self-citationFibrinogen gamma-chain splice variant γ′ alters fibrin formation and structure
Cooper, A. V., Standeven, K. F., & Ariëns, R. A. S. (2003) · Blood · doi:10.1182/blood-2002-10-3150 · Cited by 132
Self-citationWolfenstein‐Todel, C., & Mosesson, M. W. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5069 · Cited by 131
Effects of Cigarette Smoke Exposure on Clot Dynamics and Fibrin Structure
Barua, R. S., Sy, F., Srikanth, S., Huang, G. Y., Javed, U., Buhari, C. F., Margosan, D. A., & Ambrose, J. A. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.195024 · Cited by 129
Functional Analysis of the Fibrinogen Aα Thr312Ala Polymorphism
Standeven, K. F., Grant, P. J., Carter, A. M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000066690.89407.ce · Cited by 128
Molecular Basis of Fibrin Clot Elasticity
Lim, B. C. B., Lee, E. H., Sotomayor, M. M., & Schulten, K. J. (2008) · Structure · doi:10.1016/j.str.2007.12.019 · Cited by 128
Cross-linking site in fibrinogen for alpha 2-plasmin inhibitor.
Kimura, S., & Aoki, N. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)66755-9 · Cited by 124
Binding of fibronectin by the acute phase reactant C-reactive protein.
Salonen, E., VARTIO, T., Hedman, K., & Vaheri, A. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43435-1 · Cited by 124
Effects of Aspirin on Clot Structure and Fibrinolysis Using a Novel In Vitro Cellular System
Ajjan, R., Standeven, K. F., Khanbhai, M., et al. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.183707 · Cited by 117
Ammollo, C. T., Semeraro, F., Incampo, F., Semeraro, N., & Colucci, M. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03739.x · Cited by 115
Meltzer, M. E., Lisman, T., Doggen, C. J. M., de Groot, P. G., & Rosendaal, F. R. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050097 · Cited by 114
Fibrinogen β-Chain Tyrosine Nitration Is a Prothrombotic Risk Factor
Parastatidis, I., Thomson, L., Burke, A., Chernysh, I. N., Nagaswami, C., Visser, J., Stamer, S. L., Liebler, D. C., Koliakos, G., Heijnen, H. F. G., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805522200 · Cited by 110
Sauls, D. L., Wolberg, A. S., & Hoffman, M. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00053.x · Cited by 109
Altered properties of the fibrin gel structure in patients with IDDM
Jörneskog, G., Egberg, N., Fagrell, B., Fatah, K., HESSEL, B., Johnsson, H., Brismar, K., & Blombäck, M. (1996) · Diabetologia · doi:10.1007/s001250050607 · Cited by 107
Fibrin clot properties in acute ischemic stroke: relation to neurological deficit
Undas, A., Słowik, A., Wołkow, P. P., Szczudlik, A., & Tracz, W. (2009) · Thrombosis Research · doi:10.1016/j.thromres.2009.11.013 · Cited by 106
Self-citationStandeven, K. F., Ariëns, R. A. S., Whitaker, P., Ashcroft, A. E., Weisel, J. W., & Grant, P. J. (2002) · Diabetes · doi:10.2337/diabetes.51.1.189 · Cited by 106
Factor XIII‐mediated cross‐linking of NH2‐terminal peptide of α2‐plasmin inhibitor to fibrin
Ichinose, A., Tamaki, T., & Aoki, N. (1983) · FEBS Letters · doi:10.1016/0014-5793(83)80645-0 · Cited by 105
The molecular basis of homocysteine thiolactone-mediated vascular disease
Jakubowski, H. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.338 · Cited by 104
Fibrinopeptides A and B release in the process of surface fibrin formation
Riedel, T., Suttnar, J., Brynda, E., et al. (2010) · Blood · doi:10.1182/blood-2010-08-300301 · Cited by 99
Fibrin clot properties are altered in patients with chronic obstructive pulmonary disease
Kaczmarek, P., Sładek, K., Stępień, E. Ł., Skucha, W., Rzeszutko, M., Górkiewicz-Kot, I., Tracz, W., & Undas, A. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-02-0118 · Cited by 96
Self-citationWells, P. S., Anderson, J. L., Scarvelis, D., Doucette, S. P., & Gagnon, F. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj179 · Cited by 96
Schneider, M. M., & Nesheim, M. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313164200 · Cited by 93
Fibrinogen Non‐Inherited Heterogeneity and Its Relationship to Function in Health and Disease
Henschen-Edman, A. H. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03546.x · Cited by 93
Prothrombotic Consequences of the Oxidation of Fibrinogen and their Inhibition by Aspirin
Upchurch, G. R., Ramdev, N., Walsh, M. T., & Loscalzo, J. (1998) · Journal of Thrombosis and Thrombolysis · doi:10.1023/a:1008859729045 · Cited by 88
Fibrin clot structure in patients with end-stage renal disease
Sidelmann, J. J., Brabrand, M., Pedersen, R. S., Pedersen, J., Esbensen, K. H., Standeven, K. F., Ariëns, R. A. S., Gram, J., & Sjøland, J. A. (2007) · Thrombosis and Haemostasis · doi:10.1160/th06-12-0715 · Cited by 88
Self-citationCross-linking of Plasminogen Activator Inhibitor 2 and α2-Antiplasmin to Fibrin(ogen)
Ritchie, H. M., Lawrie, L. C., Crombie, P. W., Mosesson, M. W., & Booth, N. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002901200 · Cited by 87
Ajjan, R., Lim, B. C. B., Standeven, K. F., Harrand, R., Dolling, S., Phoenix, F. A., Greaves, R. B., Abou‐Saleh, R. H., Connell, S. D., Smith, D. A. M., et al. (2007) · Blood · doi:10.1182/blood-2007-05-091231 · Cited by 86
Self-citationPlasma levels of fibrinolytic proteins and the risk of myocardial infarction in men
Meltzer, M. E., Doggen, C. J. M., de Groot, P. G., Rosendaal, F. R., & Lisman, T. (2010) · Blood · doi:10.1182/blood-2010-01-263103 · Cited by 82
Undas, A., Plicner, D., Stępień, E. Ł., Drwiła, R., & Sadowski, J. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02637.x · Cited by 81
Self-citationFatah, K., BEVING, H. F. G., Albåge, A., et al. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015070 · Cited by 81
Lipoprotein(a) as a modifier of fibrin clot permeability and susceptibility to lysis
Undas, A., Stępień, E. Ł., Tracz, W., & Szczeklik, A. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01903.x · Cited by 81
Self-citationHypofibrinolysis is a risk factor for arterial thrombosis at young age
Guimarães, A. H. C., de Bruijne, E. L. E., Lisman, T., Dippel, D. W. J., Deckers, J. W., Poldermans, D., Rijken, D. C., & Leebeek, F. W. G. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07568.x · Cited by 80
Ebbing, M., Bønaa, K. H., Arnesen, E., Ueland, P. M., Nordrehaug, J. E., Rasmussen, K., Njølstad, I., Nilsen, D. W. T., Refsum, H., Tverdal, A., et al. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02259.x · Cited by 80
Undas, A., Kolarz, M., Kopeć, G., & Tracz, W. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm884 · Cited by 77
Self-citationCampbell, R. A., Overmyer, K. A., Bagnell, C. R., & Wolberg, A. S. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.176008 · Cited by 77
Genetics of fibrin clot structure: a twin study
Dunn, E. J., Ariëns, R. A. S., de Lange, M., Snieder, H., Turney, J. H., Spector, T. D., & Grant, P. J. (2003) · Blood · doi:10.1182/blood-2003-07-2247 · Cited by 74
Self-citationHouser, J. R., Hudson, N. E., Ping, L., O’Brien, E. T., Superfine, R., Lord, S. T., & Falvo, M. R. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.08.060 · Cited by 73
Curnow, J. L., Morel‐Kopp, M., Roddie, C., Aboud, M., & Wård, C. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02362.x · Cited by 68
Jaleel, A., Halvatsiotis, P., Williamson, B., Juhász, P., Martin, S., & Nair, K. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.645 · Cited by 68
Undas, A., Nowakowski, T., Cieśla‐Dul, M., & Sadowski, J. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.12.040 · Cited by 65
Self-citationBlombäck, M., He, S., Bark, N., Wallén, H., & Elg, M. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08546.x · Cited by 64
Better increase in fibrin gel porosity by low dose than intermediate dose acetylsalicylic acid
Williams, S. (1998) · European Heart Journal · doi:10.1053/euhj.1998.1088 · Cited by 62
Barua, R. S., Sy, F., Srikanth, S., Huang, G. Y., Javed, U., Buhari, C. F., Margosan, D. A., Aftab, W., & Ambrose, J. A. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.07.021 · Cited by 60
Unfavorably altered fibrin clot properties in patients with active rheumatoid arthritis
Kwaśny-Krochin, B., Głuszko, P., & Undas, A. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.04.007 · Cited by 57
Self-citation一次的フィブリン重合ポケット ペプチドGly‐Pro‐Arg‐Proと複合した30kDaのC端γ鎖断片の三次元構造
Pratt, K. P., Côté, H. C. F., Chung, D. W., Stenkamp, R. E., & Davie, E. W. (1997) · Proceedings of the National Academy of Sciences · Cited by 54
Burton, R. A., Tsurupa, G., Medved, L. V., & Tjandra, N. (2006) · Biochemistry · doi:10.1021/bi052380c · Cited by 53
Zalewski, J., Undas, A., Godlewski, J., Stępień, E. Ł., & Zmudka, K. F. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.149633 · Cited by 53
Self-citationUndas, A., Stïpień, E., Głowacki, R., Tisończyk, J., Tracz, W., & Jakubowski, H. (2006) · Thrombosis and Haemostasis · doi:10.1160/th06-04-0228 · Cited by 46
Self-citationJörneskog, G., Hansson, L.-O., Wallén, N. H., Yngen, M., & Blombäck, M. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00301.x · Cited by 45
Effects of homocysteine thiol group on fibrin networks: another possible mechanism of harm
Lauricella, A. M., Quintana, I. L., & Kordich, L. (2002) · Thrombosis Research · doi:10.1016/s0049-3848(02)00191-3 · Cited by 43
He, S., Bark, N., Wang, H., et al. (2009) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181953e0f · Cited by 41
Bhasin, N., Ariëns, R. A. S., West, R. M., Parry, D. J., Grant, P. J., & Scott, D. J. A. (2008) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2008.07.010 · Cited by 39
Self-citationBröijersén, A., Hamsten, A., Silveira, A. M. V., Fatah, K., Goodall, A. H., Eriksson, S., Angelin, B., & Hjemdahl, P. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650548 · Cited by 32
Tsurupa, G., Ho‐Tin‐Noé, B., Anglés‐Cano, E., & Medved, L. V. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305154200 · Cited by 31
Alteration of fibrin clot properties by ultrafine particulate matter
Metassan, S., Charlton, A., Routledge, M. N., Scott, D. J. A., & Ariëns, R. A. S. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-05-0330 · Cited by 20
Self-citationIdentification of Quantitative Trait Loci for Fibrin Clot Phenotypes: The EuroCLOT Study
Williams, F. M. K., Carter, A. M., Kato, B. S., Falchi, M., Bathum, L., Surdulescu, G. L., Kyvik, K. O., Palotie, A. V., Spector, T. D., & Grant, P. J. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.178103 · Cited by 17
Cited by
Fibrinolysis and the control of blood coagulation
Chapin, J. C., & Hajjar, K. A. (2015) · Blood Reviews · doi:10.1016/j.blre.2014.09.003 · Cited by 839
Fibrin Formation, Structure and Properties
Weisel, J. W., & Litvinov, R. I. (2017) · Subcellular Biochemistry · doi:10.1007/978-3-319-49674-0_13 · Cited by 729
Kell, D. B., & Pretorius, E. (2014) · Metallomics · doi:10.1039/c3mt00347g · Cited by 667
Mechanisms of fibrin polymerization and clinical implications
Weisel, J. W., & Litvinov, R. I. (2013) · Blood · doi:10.1182/blood-2012-09-306639 · Cited by 516
New insights into the mechanisms of venous thrombosis
Mackman, N. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60229 · Cited by 436
Metadata
- Authors
- Undas, A., & Ariëns, R. A. S.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2011-12
- Volume
- 31
- Issue
- 12
- Pages
- e88-99
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2154036638
- Cited by
- 526
- References
- 105
- FWCI
- 22.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.